Iron toxicity and its possible association with treatment of Cancer: Lessons from hemoglobinopathies and rare, transfusion-dependent anemias
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 79, 343-351
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- Hepcidin-Induced Endocytosis of Ferroportin Is Dependent on Ferroportin UbiquitinationCell Metabolism, 2012
- Iron Metabolism: Interactions with Normal and Disordered ErythropoiesisCold Spring Harbor Perspectives in Medicine, 2012
- Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief reviewLeukemia Research, 2011
- Crosstalk between Erythropoiesis and Iron MetabolismAdvances in Hematology, 2010
- Ferroportin and Erythroid Cells: An UpdateAdvances in Hematology, 2010
- Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin ironAnnals of the New York Academy of Sciences, 2010
- Cancer and Inflammation: Promise for Biologic TherapyJournal of Immunotherapy, 2010
- Oxidative Stress in the Regulation of Normal and Neoplastic HematopoiesisAntioxidants & Redox Signaling, 2008
- Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized TrialJNCI: Journal of the National Cancer Institute, 2008